IMUGENE LIMITED — Capital/Financing Update 2022

Nov 2, 2022

==> picture [178 x 31] intentionally omitted <==

3 November 2022

ASX ANNOUNCEMENT

Notice Under Section 708A(5) of the Corporations Act 2001

This notice is given by Imugene Limited (ACN 009 179 551) (ASX:IMU) (IMU or the Company) under

section 708A(5)(e) of the Corporations Act 2001 (Cth) (the Corporations Act).

Type	Shares
Class/description	Ordinary
ASX code	IMU
Date of issue	2 November 2022
Number issued and issue price per security	5,000,000 @ $0.040 ea.
Number issued and issue price per security	10,000,000 @ $0.042 ea.
Number issued and issue price per security	20,000,000 @ $0.045 ea.

The Company gives notice under section 708A(5)(e) of the Corporations Act that:

1. the Company issued the Shares without disclosure under Part 6D.2 of the Corporations Act;

2. as at the date of this notice the Company has complied with:

   • (i) the provisions of Chapter 2M of the Corporations Act as they apply to the Company; and

   • (ii) section 674 and 674A of the Corporations Act; and

3. as at the date of this notice, there is no information to be disclosed which is ‘excluded information’ (as defined in sections 708A(7) and 708A(8) of the Corporations Act) which is required to be disclosed by the Company.

For and on behalf of the Company,

Phillip Hains

Company Secretary

info@imugene.com

IMUGENE LIMITED ACN 009 179 551

WWW.IMUGENE.COM